| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.15▼ | 1.16▼ | 1.16▼ | 1.10▲ | 0.96▲ |
| MA10 | 1.16▼ | 1.16▼ | 1.17▼ | 1.01▲ | 1.03▲ |
| MA20 | 1.16▼ | 1.16▼ | 1.14▼ | 0.94▲ | 1.10▲ |
| MA50 | 1.15▼ | 1.10▲ | 1.03▲ | 1.02▲ | 1.22▼ |
| MA100 | 1.09▲ | 1.02▲ | 0.97▲ | 1.09▲ | N/A |
| MA200 | 1.01▲ | 1.03▲ | 1.05▲ | 1.34▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.008▼ | -0.008▼ | 0.035▲ | 0.004▲ |
| RSI | 44.476▼ | 49.966▼ | 56.072▲ | 60.453▲ | 49.684▼ |
| STOCH | 57.143 | 44.805 | 49.841 | 57.121 | 38.188 |
| WILL %R | -85.714▼ | -90.909▼ | -52.632 | -38.000 | -32.209 |
| CCI | -84.183 | -131.378▼ | -70.707 | 111.761▲ | 22.364 |
| ▲ MACD | $MIRA MACD(12,26,9) Crossed Above Zero | Set Alert |
|
Monday, March 31, 2025 05:00 PM
Virtu Financial LLC bought a new position in shares of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with ...
|
|
Thursday, January 02, 2025 01:31 PM
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.18 | 1.18 | 1.13 | 1.14 | 251,900 |
| 30/04/25 | 1.14 | 1.21 | 1.09 | 1.16 | 496,600 |
| 29/04/25 | 1.05 | 1.145 | 1.05 | 1.13 | 474,471 |
| 28/04/25 | 1.03 | 1.09 | 0.95 | 1.03 | 313,541 |
| 25/04/25 | 1.01 | 1.08 | 0.9848 | 1.04 | 624,329 |
| 24/04/25 | 0.92 | 1.03 | 0.90 | 0.994 | 697,600 |
| 23/04/25 | 0.8744 | 0.9895 | 0.8424 | 0.921 | 4,777,667 |
| 22/04/25 | 0.85 | 0.8901 | 0.84 | 0.8601 | 288,842 |
| 21/04/25 | 0.917 | 0.93 | 0.8601 | 0.865 | 396,646 |
| 17/04/25 | 0.99 | 0.99 | 0.83 | 0.9389 | 1,775,403 |
|
|
||||
|
|
||||
|
|